Clinical Trial – Prevention of Severe Postpartum Hypertension– Hypertension

The purpose of this study is to determine whether postpartum administration of furosemide to women with antepartum hypertensive disorders (gestational hypertension, preeclampsia) or elevated blood pressure in the first 24 hours following delivery reduces severe postpartum hypertension.

Study Type  : Interventional  (Clinical Trial)
Estimated Enrollment  : 248 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Furosemide for Prevention of Severe Postpartum Hypertension: a Randomized Controlled Trial
Study Start Date  : August 2015
Estimated Primary Completion Date  : May 2018
Estimated Study Completion Date  : May 2018
Contacts
Contact: Shannon A Martin, RN 314-362-8523 martins@wudosis.wustl.edu

 

Locations
United States, Missouri
Washington University School of Medicine Recruiting
Saint Louis, Missouri, United States, 63110
Contact: Shannon Martin

 

ClinicalTrials.gov Identifier: NCT02450773

 

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.